vs
Clarus Corp（CLAR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Clarus Corp的1.1倍（$69.8M vs $65.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -47.8%，领先431.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -8.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -2.9%）
Clarus Corp是一家全球性企业，主营高性能户外休闲、登山、露营及生活方式产品的设计、生产与分销，旗下拥有多个知名消费品牌，为北美、欧洲及亚太地区的户外爱好者、专业运动员和零售合作伙伴提供创新耐用的运动装备。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CLAR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$65.4M
营收增速更快
RIGL
高出29.6%
-8.4%
净利率更高
RIGL
高出431.8%
-47.8%
两年增速更快
RIGL
近两年复合增速
-2.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $65.4M | $69.8M |
| 净利润 | $-31.3M | $268.1M |
| 毛利率 | 27.7% | 91.5% |
| 营业利润率 | -59.6% | 33.2% |
| 净利率 | -47.8% | 384.0% |
| 营收同比 | -8.4% | 21.2% |
| 净利润同比 | 52.3% | 1769.2% |
| 每股收益（稀释后） | $-0.81 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLARRIGL
| Q4 25 | $65.4M | $69.8M | ||
| Q3 25 | $69.3M | $69.5M | ||
| Q2 25 | $55.2M | $101.7M | ||
| Q1 25 | $60.4M | $53.3M | ||
| Q4 24 | $71.4M | $57.6M | ||
| Q3 24 | $67.1M | $55.3M | ||
| Q2 24 | $56.5M | $36.8M | ||
| Q1 24 | $69.3M | $29.5M |
净利润CLARRIGL
| Q4 25 | $-31.3M | $268.1M | ||
| Q3 25 | $-1.6M | $27.9M | ||
| Q2 25 | $-8.4M | $59.6M | ||
| Q1 25 | $-5.2M | $11.4M | ||
| Q4 24 | $-65.5M | $14.3M | ||
| Q3 24 | $-3.2M | $12.4M | ||
| Q2 24 | $-5.5M | $-1.0M | ||
| Q1 24 | $21.9M | $-8.2M |
毛利率CLARRIGL
| Q4 25 | 27.7% | 91.5% | ||
| Q3 25 | 35.1% | 93.2% | ||
| Q2 25 | 35.6% | 95.6% | ||
| Q1 25 | 34.4% | 91.7% | ||
| Q4 24 | 33.4% | 89.9% | ||
| Q3 24 | 35.0% | 85.5% | ||
| Q2 24 | 36.1% | 92.4% | ||
| Q1 24 | 35.9% | 93.1% |
营业利润率CLARRIGL
| Q4 25 | -59.6% | 33.2% | ||
| Q3 25 | -4.4% | 40.9% | ||
| Q2 25 | -19.7% | 60.1% | ||
| Q1 25 | -11.2% | 23.9% | ||
| Q4 24 | -70.2% | 28.9% | ||
| Q3 24 | -8.0% | 25.4% | ||
| Q2 24 | -14.4% | 1.2% | ||
| Q1 24 | -9.8% | -23.6% |
净利率CLARRIGL
| Q4 25 | -47.8% | 384.0% | ||
| Q3 25 | -2.3% | 40.2% | ||
| Q2 25 | -15.3% | 58.6% | ||
| Q1 25 | -8.7% | 21.5% | ||
| Q4 24 | -91.8% | 24.9% | ||
| Q3 24 | -4.7% | 22.5% | ||
| Q2 24 | -9.7% | -2.8% | ||
| Q1 24 | 31.6% | -27.9% |
每股收益（稀释后）CLARRIGL
| Q4 25 | $-0.81 | $14.11 | ||
| Q3 25 | $-0.04 | $1.46 | ||
| Q2 25 | $-0.22 | $3.28 | ||
| Q1 25 | $-0.14 | $0.63 | ||
| Q4 24 | $-1.72 | $0.82 | ||
| Q3 24 | $-0.08 | $0.70 | ||
| Q2 24 | $-0.14 | $-0.06 | ||
| Q1 24 | $0.57 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.7M | $155.0M |
| 总债务越低越好 | $0 | $52.5M |
| 股东权益账面价值 | $196.4M | $391.5M |
| 总资产 | $249.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CLARRIGL
| Q4 25 | $36.7M | $155.0M | ||
| Q3 25 | $29.5M | $137.1M | ||
| Q2 25 | $28.5M | $108.4M | ||
| Q1 25 | $41.3M | $77.1M | ||
| Q4 24 | $45.4M | $77.3M | ||
| Q3 24 | $36.4M | $61.1M | ||
| Q2 24 | $46.2M | $49.1M | ||
| Q1 24 | $47.5M | $49.5M |
总债务CLARRIGL
| Q4 25 | $0 | $52.5M | ||
| Q3 25 | $2.0M | $60.0M | ||
| Q2 25 | $1.9M | $60.0M | ||
| Q1 25 | $1.9M | $60.0M | ||
| Q4 24 | $1.9M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $37.0K | $60.0M |
股东权益CLARRIGL
| Q4 25 | $196.4M | $391.5M | ||
| Q3 25 | $225.8M | $117.6M | ||
| Q2 25 | $225.1M | $81.9M | ||
| Q1 25 | $229.3M | $18.6M | ||
| Q4 24 | $233.1M | $3.3M | ||
| Q3 24 | $308.5M | $-14.6M | ||
| Q2 24 | $307.3M | $-29.9M | ||
| Q1 24 | $310.4M | $-31.7M |
总资产CLARRIGL
| Q4 25 | $249.0M | $513.6M | ||
| Q3 25 | $283.1M | $242.5M | ||
| Q2 25 | $286.5M | $206.7M | ||
| Q1 25 | $292.8M | $176.0M | ||
| Q4 24 | $294.1M | $164.0M | ||
| Q3 24 | $375.3M | $139.4M | ||
| Q2 24 | $369.4M | $128.4M | ||
| Q1 24 | $377.0M | $126.5M |
负债/权益比CLARRIGL
| Q4 25 | 0.00× | 0.13× | ||
| Q3 25 | 0.01× | 0.51× | ||
| Q2 25 | 0.01× | 0.73× | ||
| Q1 25 | 0.01× | 3.23× | ||
| Q4 24 | 0.01× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | — |
| 自由现金流率自由现金流/营收 | 17.7% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-9.9M | — |
8季度趋势，按日历期对齐
经营现金流CLARRIGL
| Q4 25 | $12.5M | $22.0M | ||
| Q3 25 | $-5.7M | $24.0M | ||
| Q2 25 | $-9.4M | $30.5M | ||
| Q1 25 | $-2.1M | $-893.0K | ||
| Q4 24 | $16.6M | $14.5M | ||
| Q3 24 | $-8.3M | $21.7M | ||
| Q2 24 | $834.0K | $302.0K | ||
| Q1 24 | $-16.4M | $-5.0M |
自由现金流CLARRIGL
| Q4 25 | $11.6M | — | ||
| Q3 25 | $-7.0M | — | ||
| Q2 25 | $-11.3M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $-9.4M | — | ||
| Q2 24 | $-744.0K | — | ||
| Q1 24 | $-18.3M | — |
自由现金流率CLARRIGL
| Q4 25 | 17.7% | — | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | -20.4% | — | ||
| Q1 25 | -5.4% | — | ||
| Q4 24 | 20.1% | — | ||
| Q3 24 | -14.0% | — | ||
| Q2 24 | -1.3% | — | ||
| Q1 24 | -26.3% | — |
资本支出强度CLARRIGL
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.7% | — |
现金转化率CLARRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
RIGL
暂无分部数据
